JPMorgan is well positioned to outperform, driven by robust net interest income, deregulation, capital flows, and a rebound in capital markets activity. The delay of Basel III Endgame and strong Fed Stress Test results provide JPM with significant capital flexibility for dividends, buybacks, and growth initiatives. I estimate a $335 price target for JPM, reflecting a 17% upside based on forward EPS and a P/E multiple expansion to 16x/17x.

JPMorgan has reportedly told FinTechs it will begin charging for access to customer bank info. That's according to a report Friday (July 11) from Bloomberg News, which noted these fees from the largest American bank could amount to hundreds of millions of dollars, threatening the FinTech sector's business model.

Nvidia supplies the world's best artificial intelligence (AI) chips for data centers. Demand is heavily outstripping supply, sending the company's sales -- and its stock price -- surging over the last couple of years.

I rate BVN a buy on increasing gold production at lower costs that is not well valued. The San Gabriel mine ramp-up will lower gold costs and drive EBITDA to over US$600m, supporting cash earnings growth of over 16% through 2027. The stock is cheap at under 8x P/CE vs sector average of 10x, and my YE26 price target of US$26.7 has over 60% upside potential.

QQQY's original put-write 0DTE strategy led to severe NAV erosion, underperformance, and a reverse split within its first year. The fund's high advertised yield (up to 39%) is unsustainable, largely funded by return of capital, eroding investor principal. QQQY is shifting to a daily call spread strategy similar to QDTE, aiming for a 30% yield and better index participation.

Bank puts $50 billion toward lending to riskier companies to compete with nonbank giants dominating market; Walgreens deal the payoff.

CoreWeave's acquisition of Core Scientific aims to verticalize data center ownership and cut $500 million in costs by 2027. The deal gives CoreWeave direct control over data center assets, enabling faster, tailored AI infrastructure deployments and improved cost efficiency. Despite operational benefits, the market reacted negatively, with CoreWeave shares dropping and the deal value for Core Scientific shareholders declining.

GLENDALE, Calif.--(BUSINESS WIRE)--Ki Corporation and Public Storage (NYSE:PSA) (together, the “Consortium”) announced today a revised non-binding indicative offer (NBIO) to acquire Abacus Storage King (ASX:ASK) for cash consideration of A$1.65 per stapled security. The Consortium and Abacus Storage King have agreed to proceed with due diligence based on the revised terms. “We are excited to take the next step towards this potential combination with Abacus Storage King in partnership with Ki Co.

NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

The third quarter earnings season kicks off with an abundance of big reports across industries. Among the most notable names: JPMorgan Chase (JPM), United Airlines (UAL), and TSMC (TSM).

Two weeks after it began offering tokenized equities, Robinhood Markets is dealing with continued fallout. A report Saturday (July 12) by Bloomberg examines the brokerage's struggles in the wake of the new offering, which launched a $1 million giveaway of SpaceX and OpenAI tokens.

Siemens and SAP CEOs have urged the European Union to revise its artificial intelligence legislation, saying the current rules stifle innovation.

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies

Meta has acquired Play AI, a startup that uses AI to generate human-sounding voices.

NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “Class Period”), of the important July 21, 2025 lead plaintiff deadline.

Oil demand forecasts diverge as OPEC boosts supply, IEA turns bearish, and EIA warns of surpluses. Explore the full crude oil market outlook.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the presentation of new exploratory analyses from the Phase 2 PREVENT and Phase 2b clinical trials of avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist for the treatment of post-bariatric hypoglycemia (PBH) at the Endocrine Society's annual meeting (ENDO 2025). In the Phase 2b trial, avexitide 90 mg once daily, the dose being.

Meta has reportedly acquired voice technology/artificial intelligence (AI) startup PlayAI. The “entire PlayAI team” is due to join Meta this week, Bloomberg News reported late Friday (July 11), citing an internal memo.

Amazon says its longest Prime Day sale was also its biggest. The eCommerce giant announced Saturday (July 12) that its yearly summer sale produced record sales and savings in its newly expanded four-day form.

NEW YORK , July 13, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against XPLR Infrastructure, LP ("XPLR" or "the Company") (NYSE: XIFR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired XPLR securities between September 27, 2023 and January 27, 2025, both dates inclusive (the "Class Period").